Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESGregg M. Gellman Appointed CEO of Open Implants: Offers Deep Medical Device...

Gregg M. Gellman Appointed CEO of Open Implants: Offers Deep Medical Device Development & Manufacturing Business Development Experience

February 3, 2021

Gregg M. Gellman has more than 15 years of experience, leading and growing biomedical companies. He brings a unique and strong skill set to the company.

Gellman’s previous experience includes executive leadership roles at EBI Biomet, now Zimmer Biomet, Greatbatch now Integer Holdings, EnerMed now Garwood Medical, StimMed and Thinking Robot Studios where he will continue to serve as a Board Member for both companies. He has a proven track record in product development, commercialization of regulated applications/products, regulatory and sales. Gellman is a graduate of the State University of New York at Buffalo. He is certified in Quality Systems for Medical Devices (FDA’s QSR and ISO 13485) and in Global Product Submissions Directive Requirements (510(k), PMA, CE Mark).

Greg M. Gellman feels this is a tremendous opportunity to contribute to building on what Open Implants has already accomplished. “My roots are in orthopedics, regulated manufacturing and advanced technologies and I look forward to working with customers and the Open Implants team to accelerate product development and increase our commitments to insure customer satisfaction and above all positive clinical outcomes for patients who require dental surgery.”

Rob Nazzal, Co-founder and Board Member, says, “Gregg’s deep experience in medical device development, manufacturing, and business development, will be an enormous asset for Open Implants. With Gregg onboard, we are accelerating our roadmap to deliver more comprehensive solutions to the evolving digital dentistry world. We are privileged to have Gregg on our team.”

Gregg M. Gellmen succeeds Frederic Rapp, who is also a co-founder of Open Implants. Rapp will continue as a member of the Board of Directors and will also continue full-time leadership of his dental laboratory, CrownCeram, in France.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy